Cameco Corporation

New York Stock Exchange
Back to all articles
Somewhat Bullish +45

Barclays Issues Pessimistic Forecast for Cameco (TSE:CCO) Stock Price

📉 Barclays lowered its price target for Cameco from C$149.00 to C$147.00, suggesting a potential upside of 22.57% from the current price.

📈 The broader analyst consensus remains bullish with an average rating of 'Moderate Buy' and a consensus target price of C$176.17.

🏦 Major institutions including National Bank Financial, Royal Bank of Canada, Canaccord Genuity, William Blair, and Truist Financial have recently upgraded or raised their targets for the stock.

💰 Cameco reported Q1 earnings with EPS of C$0.47, a net margin of 18.39%, and revenue of C$845.37 million.

⛏️ The McArthur River mine in Saskatchewan accounts for roughly 50% of the company's uranium output under normal production conditions.

📉 Due to prolonged uranium price weakness, Cameco has reduced production at its flagship mine and is sourcing from the spot market to meet delivery contracts.

👤 Insider Alexandre Aubin sold 300 shares on June 25th for a total value of C$44,559.00, representing a 93.75% decrease in his personal ownership.

🏭 Cameco operates uranium conversion and fabrication facilities in addition to its primary mining operations.

🚀 The company retains the long-term ability to increase annual production by restarting shut mines and investing in new projects.

Bullish Signals
  • The consensus analyst rating is 'Moderate Buy' with a target price of C$176.17, which implies significant upside potential from recent levels.
  • Multiple major banks including National Bank Financial, Royal Bank of Canada, and Canaccord Genuity have recently raised their price targets for Cameco.
  • William Blair and Truist Financial have issued 'strong-buy' ratings, indicating strong confidence in the company's long-term prospects.
  • Cameco reported a healthy net margin of 18.39% and solid revenue of C$845.37 million in the most recent quarter.
  • The company possesses significant operational flexibility to increase production by restarting shut mines or developing new ones.
Risk Factors
  • Barclays has issued a pessimistic forecast by lowering its price target, creating a divergence from other major analysts.
  • Insider Alexandre Aubin sold 300 shares, reducing his ownership stake by 93.75%, which may signal a lack of confidence at the executive level.
  • The company has been forced to reduce production at its flagship McArthur River mine due to years of uranium price weakness.
Full Analysis
Barlycs has lowered its price target for Cameco (NYSE:CCJ, TSE:CCO) from C$149.00 to C$147.00 in a research note issued on Thursday, July 18th, 2026. Despite this specific downgrade, the consensus analyst sentiment remains positive, with an average rating of 'Moderate Buy' and a consensus target price of C$176.17. The company has received significant support from other major institutions recently; National Bank Financial lifted its target to C$180.00, Royal Bank of Canada raised it to C$175.00, Canaccord Genuity increased it to C$195.00, and both William Blair and Truist Financial upgraded the stock to 'strong-buy' ratings in April and July respectively. Cameco reported quarterly earnings on May 5th with EPS of C$0.47, a net margin of 18.39%, and revenue of C$845.37 million. The company operates as one of the world's largest uranium producers, with its flagship McArthur River mine in Saskatchewan accounting for approximately 50% of output under normal conditions. To manage through years of uranium price weakness, Cameco has temporarily reduced production at this site and is purchasing from the spot market to fulfill contracted deliveries. Recent insider activity shows Alexandre Aubin sold 300 shares on June 25th at an average price of C$148.53, reducing his direct ownership by 93.75% to just 20 shares worth C$2,970.60. Corporate insiders collectively own 0.15% of the stock. While the company maintains a strong balance sheet and operational capacity to restart shut mines or invest in new ones for long-term production growth, the immediate market focus is on the divergence between Barclays' pessimistic forecast and the broader analyst consensus.